KNOREX LTD CL.A

As of December 31, 2025, KNOREX reports a shareholders' equity deficit of $6.5 million and has recorded net losses in each of the past four fiscal years, meaning the company does not meet NYSE American equity requirements. NYSE American requires minimum shareholders' equity of $2.0 million or $4.0 million depending on loss history. KNOREX intends to submit an action plan by September 20, 2026, to regain compliance by February 21, 2028. The listing of the common shares remains unchanged for now. KNOREX provides AI-powered technologies for cross-channel programmatic advertising. » Plus sur de.investing.com

The audit report on Knorex’s annual financial statements for the fiscal year ended December 31, 2025, contains a going‑concern qualification from the independent auditor. Although the consolidated financial statements were prepared on a going‑concern basis, disclosure is required under Section 610(b) of the NYSE American Company Guide. Knorex emphasizes that the notice does not constitute an amendment to previously filed documents. » Plus sur de.investing.com

KNOREX missed the extended deadline to file Form 20‑F for the fiscal year ended 31 December 2025 (extended to 15 May 2026) and received a reprimand from NYSE Regulation. The NYSE American will monitor the filing through 15 November 2026; continued failure could lead to trading suspension and delisting by no later than May 2027. KNOREX cites time constraints in preparing the filing and is working with auditors and advisers on the submission, but is also under significant financial pressure with a sharply fallen share price, a negative liquidity ratio and losses last year. » Plus sur de.investing.com